by Lara Bartlett | Jun 28, 2017 | SMART Life Science
End-to-end vs. Track-and-trace verification The ever-growing threats of illegal (falsified or substandard) pharmaceuticals entering the legal supply chain require specifications of systems effectuating measures to improve patient safety. These are defined by...
by Lara Bartlett | May 7, 2015 | SMART Life Science
“Companies spend millions of dollars on firewalls, encryption and secure access devices, and it’s money wasted, because none of these measures address the weakest link in the security chain”....
